McAbee D D, Esbensen K
Department of Biological Sciences, University of Notre Dame, Indiana 46556.
J Biol Chem. 1991 Dec 15;266(35):23624-31.
We characterized binding and endocytosis of 125I-bovine lactoferrin by isolated rat hepatocytes. Iron-depleted (apo-Lf), approximately 30% saturated (Lf), and iron-saturated (holo-Lf) lactoferrin were used. At 4 degrees C, cells bound 125I-apo-Lf and 125I-holo-Lf with nearly identical apparent first order kinetics (t1/2 = approximately 42 min). Holo-Lf and apo-Lf competed with each other for binding. Hepatocytes bound lactoferrin optimally at pH greater than or equal to 7 but poorly at pH less than or equal to 6. Ca2+ (greater than or equal to 100 microM) enhanced Lf binding to cells, and holo-Lf remained monomeric with Ca2+ present as determined by gel filtration chromatography. With Ca2+, cells exhibited approximately 10(6) high affinity sites (Kd approximately 20 nM) and approximately 10(7) low affinity sites (Kd approximately 700 nM) for both apo- and holo-Lf. Without Ca2+, cells bound 125I-holo-Lf by the low affinity component only. EGTA and dextran sulfate together released greater than or equal to 90% 125I-Lf prebound at 4 degrees C, but individually removed separate populations of surface-bound 125I-Lf. Cells bound 125I-Lf in a Ca(2+)-dependent manner with dextran sulfate present. We conclude that the high affinity but not the low affinity sites require Ca2+; only the low affinity sites are dextran sulfate-sensitive. Neither transferrin nor asialo-orosomucoid blocked lactoferrin binding to hepatocytes. Some cationic proteins but not others inhibited lactoferrin binding. At 37 degrees C, hepatocytes endocytosed 125I-apo-Lf and 125I-holo-Lf similarly, and hyperosmolality (greater than 500 mmol/kg) blocked uptake by approximately 90%. These data support the proposal that hepatocytes regulate blood lactoferrin concentration by receptor-mediated endocytosis.
我们通过分离的大鼠肝细胞对125I-牛乳铁蛋白的结合和内吞作用进行了表征。使用了缺铁(脱铁乳铁蛋白)、饱和度约为30%(乳铁蛋白)和铁饱和(全乳铁蛋白)的乳铁蛋白。在4℃时,细胞以几乎相同的表观一级动力学(t1/2约为42分钟)结合125I-脱铁乳铁蛋白和125I-全乳铁蛋白。全乳铁蛋白和脱铁乳铁蛋白相互竞争结合。肝细胞在pH大于或等于7时能最佳地结合乳铁蛋白,而在pH小于或等于6时结合较差。Ca2+(大于或等于100 microM)增强了乳铁蛋白与细胞的结合,通过凝胶过滤色谱法测定,在有Ca2+存在时全乳铁蛋白保持单体状态。有Ca2+时,细胞对脱铁乳铁蛋白和全乳铁蛋白均表现出约10^6个高亲和力位点(Kd约为20 nM)和约10^7个低亲和力位点(Kd约为700 nM)。没有Ca2+时,细胞仅通过低亲和力成分结合125I-全乳铁蛋白。EGTA和硫酸葡聚糖一起能释放出在4℃时预先结合的90%以上的125I-乳铁蛋白,但单独使用时能去除不同群体的表面结合的125I-乳铁蛋白。在有硫酸葡聚糖存在时,细胞以Ca(2+)依赖的方式结合125I-乳铁蛋白。我们得出结论,高亲和力位点而非低亲和力位点需要Ca2+;只有低亲和力位点对硫酸葡聚糖敏感。转铁蛋白和去唾液酸血清类黏蛋白均未阻断乳铁蛋白与肝细胞的结合。一些阳离子蛋白能抑制乳铁蛋白结合,而其他阳离子蛋白则不能。在37℃时,肝细胞对125I-脱铁乳铁蛋白和125I-全乳铁蛋白的内吞作用相似,高渗(大于500 mmol/kg)可使摄取量减少约90%。这些数据支持肝细胞通过受体介导的内吞作用调节血液乳铁蛋白浓度这一观点。